The Scientist - Home

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

After refusing to pay the ransom demanded by those behind a cyberattack, the Netherlands Organisation for Scientific Research has been out of action since February 8.

The cephalopods resisted temptation for up to 130 seconds to earn their favorite food, hinting at sophisticated cognitive abilities such as planning for the future.

An interactive online forum keeps Indian kids busy with science while they are stuck indoors during the pandemic.

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

Instead, the full report will be available in mid-March.

The decision adds to evidence that the benefits of plasma infusions from COVID-19 survivors may be limited, but advocates say the case isn’t closed.

The roundworm uses cues from visible light to help avoid eating toxic bacteria with a distinguishing hue.

Clinics are popping up around the US to study the sometimes long-lasting effects of SARS-CoV-2 infection in children and teens.

Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

The species include the first reptile to be listed and the Christmas Island pipistrelle, a bat last seen in 2009.

A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.